Stop parsing PDFs. Get the API. Request Access

AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Novonesis AS

Transaction in Own Shares • Mar 21, 2022

3377_dirs_2022-03-21_fc19273a-5dd5-420d-a2bf-6988c1ade891.pdf

Transaction in Own Shares

Open in Viewer

Opens in native device viewer

Transactions under Novozymes' stock buyback program

As of March 21st, 2022, Novozymes has purchased an accumulated 257,410 shares with a transaction value of DKK 105.8 million under the stock buyback program Novozymes announced in Company announcement No. 2, 2022 and initiated February 21st, 2022. Under the program, Novozymes will buy back B shares worth up to DKK 500 million in total during 2022.

The following transactions have been made under the program in accordance with the European Commission regulation 596/2014 of 16 April 2014, also known as the "Market Abuse Regulation", and regulation 1052/2016 of 8 March 2016:

Number of shares Average purchase price Transaction value, DKK
Accumulated, last announcement 246,085 101,128,566
14 March 2022 1,780 393.36 700,174
15 March 2022 5,028 404.32 2,032,918
16 March 2022 - -
17 March 2022 - -
18 March 2022 4,517 435.64 1,967,777
Accumulated under the program 257,410 105,829,435

In addition, transactions necessitated by Novozymes' previously established incentive programs have resulted in a net sale by Novozymes of 1,017 B shares in the period from March 14th, 2022 to March 18th, 2022. The share transactions related to the incentive programs were not part of the Market Abuse Regulation stock buyback program.

Following the transactions stated above, Novozymes owns a total of 4,965,449 treasury shares, corresponding to 1.8 % of the stock capital. The total number of shares in the company is 282,000,000 including treasury shares.

March 21st, 2022 Company announcement No. 7

Contact information

[email protected]

Tobias Cornelius Björklund +45 3077 8682 [email protected]

Carl Ahlgren +1 919 702 6144 [email protected]

Ulrik Wu Svare +45 3077 3187 [email protected]

About Novozymes

Novozymes is the world leader in biological solutions. Together with customers, partners and the global community, we improve industrial performance while preserving the planet's resources and helping build better lives. As the world's largest provider of enzyme and microbial technologies, our bioinnovation enables higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel and many other benefits that we rely on today and in the future. We call it Rethink Tomorrow. www.novozymes.com

Novozymes A/S CVR number: 10 00 71 27 LEI: 529900T6WNZXD2R3JW38

Novozymes A/S Krogshoejvej 36 2880 Bagsvaerd

Denmark Phone: +45 4446 0000

Appendix – Detailed trading data on Novozymes A/S's share buy-back transactions for the period mentioned above.

All trades have been carried out by Nordea.

14-03-2022
XCSE
DCSE
BATE
BATD
CHIX
CHID
TRQX
TRQM
XNOR
Total		 Number of Shares 1,780
1,780		 VWAP DKK
393.36
393.36		 Gross Value DKK
700,174
700,174
15-03-2022
XCSE
DCSE
BATE
BATD
CHIX
CHID
TRQX
TRQM
XNOR
Total		 Number of Shares 5,028
5,028		 VWAP DKK
404.32
404.32		 Gross Value DKK
2,032,918
2,032,918
16-03-2022
XCSE
DCSE
BATE
BATD
CHIX
CHID
TRQX
TRQM
XNOR
Total		 Number of Shares -
-		 VWAP DKK
-		 Gross Value DKK
-
-
17-03-2022
XCSE
DCSE
BATE
BATD
CHIX
CHID
TRQX		 Number of Shares - VWAP DKK Gross Value DKK
-
TRQM
XNOR
Total		 - -
-
18-03-2022
XCSE
DCSE
BATE
BATD
CHIX
CHID
TRQX
TRQM
XNOR		 Number of Shares VWAP DKK
4,517
435.64		 Gross Value DKK
1,967,777
Total 4,517
435.64		 1,967,777
170 394,00
XCSE		 20220314 09:07:43 14-03-2022
130 394,90
XCSE		 20220314 09:10:01 14-03-2022
170 394,20
XCSE		 20220314 09:10:38 14-03-2022
152 393,20
XCSE		 20220314 09:15:39 14-03-2022
8 393,20
XCSE		 20220314 09:15:39 14-03-2022
140 392,30
XCSE		 20220314 09:15:50 14-03-2022
110 393,00
XCSE		 20220314 09:17:12 14-03-2022
20
150		 390,80
XCSE
390,80
XCSE		 20220314 09:21:47
20220314 09:21:47		 14-03-2022
14-03-2022
150
124		 391,10
XCSE
391,00
XCSE		 20220314 09:26:27
20220314 09:26:27		 14-03-2022
14-03-2022
16 391,00
XCSE		 20220314 09:26:27 14-03-2022
170 392,40
XCSE		 20220314 09:30:27 14-03-2022
124 391,00 XCSE 20220314 09:26:27 14-03-2022
16 391,00 XCSE 20220314 09:26:27 14-03-2022
170 392,40 XCSE 20220314 09:30:27 14-03-2022
150 396,50 XCSE 20220314 09:35:22 14-03-2022
120 396,50 XCSE 20220314 09:39:39 14-03-2022
60 406,00 XCSE 20220315 10:08:46 15-03-2022
150 406,00 XCSE 20220315 10:08:46 15-03-2022
180 405,30 XCSE 20220315 10:11:38 15-03-2022
220 404,70 XCSE 20220315 10:12:09 15-03-2022
160 404,90 XCSE 20220315 10:21:12 15-03-2022
150 404,40 XCSE 20220315 10:21:41 15-03-2022
170 404,40 XCSE 20220315 10:21:41 15-03-2022
170 401,00 XCSE 20220315 10:27:51 15-03-2022
170 401,70 XCSE 20220315 10:30:00 15-03-2022
184 401,80 XCSE 20220315 10:34:31 15-03-2022
26 401,80 XCSE 20220315 10:34:31 15-03-2022
20 401,70 XCSE 20220315 10:34:31 15-03-2022
583 401,90 XCSE 20220315 10:36:42 15-03-2022
67 401,90 XCSE 20220315 10:36:42 15-03-2022
9 401,80 XCSE 20220315 10:40:30 15-03-2022
161 401,80 XCSE 20220315 10:40:30 15-03-2022
143 404,80 XCSE 20220315 10:51:08 15-03-2022
87 404,80 XCSE 20220315 10:51:08 15-03-2022
170 405,40 XCSE 20220315 10:53:52 15-03-2022
Company announcement No. 7
---------------------------- -- --
59 404,90 XCSE 20220315 10:54:16 15
121 404,90 XCSE 20220315 10:54:16 15
190 404,90 XCSE 20220315 10:58:52 15
48 404,40 XCSE 20220315 11:01:21 15
82 405,00 XCSE 20220315 11:11:04 15
199 405,00 XCSE 20220315 11:11:04 15
180 405,10 XCSE 20220315 11:11:04 15
91 405,00 XCSE 20220315 11:11:04 15
103 405,00 XCSE 20220315 11:11:04 15
15 405,00 XCSE 20220315 11:11:04 15
170 405,10 XCSE 20220315 11:14:37 15
240 406,00 XCSE 20220315 11:17:04 15
160 406,00 XCSE 20220315 11:23:54 15
10 405,60 XCSE 20220315 11:24:48 15
150 405,60 XCSE 20220315 11:24:48 15
168 405,30 XCSE 20220315 11:32:19 15
2 405,30 XCSE 20220315 11:32:19 15
160 405,50 XCSE 20220315 11:37:21 15
123 437,00 XCSE 20220318 09:09:42 18
17 437,00 XCSE 20220318 09:09:42 18
54 437,00 XCSE 20220318 09:11:08 18
106 437,00 XCSE 20220318 09:11:08 18
110 437,00 XCSE 20220318 09:15:22 18
110 437,00 XCSE 20220318 09:19:45 18
100 436,90 XCSE 20220318 09:24:00 18
140 436,10 XCSE 20220318 09:26:06 18
69 437,00 XCSE 20220318 09:35:40 18
51 437,00 XCSE 20220318 09:35:40 18
110 436,20 XCSE 20220318 09:36:06 18
120 436,40 XCSE 20220318 09:39:27 18
130 436,60 XCSE 20220318 09:42:10 18
24 436,30 XCSE 20220318 09:45:11 18
76 436,30 XCSE 20220318 09:45:11 18
11 436,90 XCSE 20220318 09:48:10 18
89 436,90 XCSE 20220318 09:48:10 18
100 435,90 XCSE 20220318 11:43:22 18
110 436,00 XCSE 20220318 11:46:49 18
110 435,90 XCSE 20220318 11:47:18 18
98 436,00 XCSE 20220318 12:00:59 18
120 435,60 XCSE 20220318 12:04:26 18
110 435,20 XCSE 20220318 12:09:34 18
35 435,40 XCSE 20220318 12:10:13 18
65 435,40 XCSE 20220318 12:10:13 18
79 434,10 XCSE 20220318 12:15:47 18
41 434,10 XCSE 20220318 12:16:02 18
130 433,90 XCSE 20220318 12:18:15 18
143 435,00 XCSE 20220318 12:21:55 18
11 435,00 XCSE 20220318 12:21:55 18
156 435,00 XCSE 20220318 12:21:55 18
76 435,10 XCSE 20220318 12:25:04 18
34 435,10 XCSE 20220318 12:25:04 18
97 434,70 XCSE 20220318 12:28:22 18
-03 -2022
-03 -2022
-03 -2022
-03 -2022
-03 -2022
-03 -2022
-03 -2022
-03 -2022
-03 -2022
-03 -2022
-03 -2022
-03 -2022
-03 -2022
-03 -2022
-03 -2022
-03 -2022
-03 -2022
-03 -2022
-03 -2022
-03 -2022
-03 -2022
-03 -2022
-03 -2022
-03 -2022
-03 -2022
-03 -2022
-03 -2022
-03 -2022
-03 -2022
-03 -2022
-03 -2022
-03 -2022
-03 -2022
-03 -2022
-03 -2022
-03 -2022
-03 -2022
-03 -2022
-03 -2022
-03 -2022
-03 -2022
-03 -2022
-03 -2022
-03 -2022
-03 -2022
-03 -2022
-03 -2022
-03 -2022
-03 -2022
-03 -2022
-03 -2022

-03 -2022

14 434,50
XCSE		 20220318 12:33:43 18
-03
38 434,50
XCSE		 20220318 12:33:43 18
-03
48 434,50
XCSE		 20220318 12:33:43 18
-03
224 434,40
XCSE		 20220318 12:35:02 18
-03
6 434,40
XCSE		 20220318 12:35:02 18
-03
99 434,10
XCSE		 20220318 12:38:31 18
-03
98 434,60
XCSE		 20220318 12:43:02 18
-03
97 435,50
XCSE		 20220318 12:50:34 18
-03
110 434,90
XCSE		 20220318 12:53:09 18
-03
110 434,80
XCSE		 20220318 12:53:34 18
-03
94 434,70
XCSE		 20220318 12:55:26 18
-03
200 434,90
XCSE		 20220318 12:59:21 18
-03
120 434,90
XCSE		 20220318 13:04:50 18
-03
94 435,40
XCSE		 20220318 13:09:35 18
-03
100 435,00
XCSE		 20220318 13:12:15 18
-03
110 435,00
XCSE		 20220318 13:12:15 18
-03

-2022

-2022

-2022

-2022

-2022

-2022

-2022

-2022

-2022

-2022

-2022

-2022

-2022

-2022

-2022

-2022

More from Novonesis AS

Director's Dealing 2025
Nov 21
Director's Dealing 2025
Nov 21
Director's Dealing 2025
Nov 7
Director's Dealing 2025
Nov 7
Major Shareholding Notification 2025
Nov 7
Major Shareholding Notification 2025
Nov 7
Major Shareholding Notification 2025
Nov 7
Director's Dealing 2025
Nov 4
Director's Dealing 2025
Nov 4
Major Shareholding Notification 2025
Sep 10
View all filings →

Talk to a Data Expert

Have a question? We'll get back to you promptly.